Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats

Published:2018-07-02 Issue:3 Volume:40 Page:365-373
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

He Xiang-hu,Jordan Chloe J.,Vemuri Kiran,Bi Guo-hua,Zhan Jia,Gardner Eliot L.,Makriyannis Alexandros,Wang Yan-lin,Xi Zheng-xiong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-018-0059-x.pdf

Reference69 articles.

1. Brady JE, Li G. Prevalence of alcohol and other drugs in fatally injured drivers. Addiction. 2013;108:104–14.

2. Naim-Feil J, Zangen A. Addiction. Handb Clin Neurol. 2013;116:613–30.

3. Jing L, Qiu Y, Zhang Y, Li JX. Effects of the cannabinoid CB(1) receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats. Drug Alcohol Depend. 2014;143:251–6.

4. Robson PJ. Therapeutic potential of cannabinoid medicines. Drug Test Anal. 2014;6:24–30.

5. Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, et al. Brain cannabinoid CB(2) receptors modulate cocaine’s actions in mice. Nat Neurosci. 2011;14:1160–6.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice;ACS Pharmacology & Translational Science;2024-08-08

2. β-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents;Neuropharmacology;2024-07

3. AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects;Neuropsychopharmacology;2024-04-10

4. Dysregulation of the endogenous cannabinoid system following opioid exposure;Psychiatry Research;2023-12

5. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3